We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Flexibility Urged for FDA-Approved Drugs Launching in Developing Nations
Flexibility Urged for FDA-Approved Drugs Launching in Developing Nations
June 4, 2012
Drugmakers breaking into emerging markets could see supply chain benefits and quicker product launches if these markets automatically registered FDA-approved products before testing for quality issues, according to a new study.